BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland
1997

BRCA1 5382insC Mutation in Breast and Ovarian Cancer

Sample size: 330 publication Evidence: low

Author Information

Author(s): P Mullen, WR Miller, J Mackay, DR Fitzpatrick, SP Langdon, JP Warner

Primary Institution: Imperial Cancer Research Fund, Medical Oncology Unit; University Department of Human Genetics, Western General Hospital

Hypothesis

The incidence of the BRCA1 5382insC mutation might be considerably higher for women with breast cancer within a Scottish population.

Conclusion

The study found a low but significant incidence of the BRCA1 5382insC mutation in sporadic breast cancer patients.

Supporting Evidence

  • Only one out of 250 breast cancer patients tested positive for the BRCA1 5382insC mutation.
  • None of the 80 ovarian cancer patients tested had the mutation.
  • The single positive case was a 26-year-old woman with no known family history.

Takeaway

The researchers looked for a specific gene mutation in women with breast and ovarian cancer and found it in only one breast cancer patient.

Methodology

A restriction site-generating polymerase chain reaction (RG-PCR) assay was developed to detect the BRCA1 5382insC mutation in tumor DNA from breast and ovarian cancer patients.

Limitations

The study only identified one case of the mutation in a small sample of sporadic breast cancer patients.

Participant Demographics

The study included 250 breast cancer patients aged 19-86 years and 80 ovarian cancer patients aged 25-90 years, with no known family history of cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication